PortfoliosLab logo

Dicerna Pharmaceuticals, Inc. (DRNA)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

DRNAShare Price Chart


Chart placeholderClick Calculate to get results

DRNAPerformance

The chart shows the growth of $10,000 invested in Dicerna Pharmaceuticals, Inc. on Jan 31, 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $8,309 for a total return of roughly -16.91%. All prices are adjusted for splits and dividends.


DRNA (Dicerna Pharmaceuticals, Inc.)
Benchmark (^GSPC)

DRNAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M0.61%4.32%
6M6.20%11.68%
YTD73.49%27.61%
1Y71.54%28.32%
5Y66.71%16.36%
10Y-2.32%13.23%

DRNAMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

DRNASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Dicerna Pharmaceuticals, Inc. Sharpe ratio is 0.75. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


DRNA (Dicerna Pharmaceuticals, Inc.)
Benchmark (^GSPC)

DRNADividend History


Dicerna Pharmaceuticals, Inc. doesn't pay dividends

DRNADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


DRNA (Dicerna Pharmaceuticals, Inc.)
Benchmark (^GSPC)

DRNAWorst Drawdowns

The table below shows the maximum drawdowns of the Dicerna Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Dicerna Pharmaceuticals, Inc. is 94.67%, recorded on Feb 8, 2017. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.67%Jan 31, 2014762Feb 8, 2017

DRNAVolatility Chart

Current Dicerna Pharmaceuticals, Inc. volatility is 5.12%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


DRNA (Dicerna Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Portfolios with Dicerna Pharmaceuticals, Inc.


Loading data...

More Tools for Dicerna Pharmaceuticals, Inc.